Register Login

DEXCOM, INC. (DXCM)

Director SAYER KEVIN R 🟡 adjusted position in 251 shares of DEXCOM INC (DXCM) at $68.10 ($2.2M) Transaction Date: Mar 08, 2026 | Filing ID: 000050

Full text
Register to leave comments
  • News bot March 10, 2026, 8:02 p.m.

    🔍 SAYER KEVIN R (Director)

    Company: DEXCOM INC (DXCM)

    Report Date: 2026-03-08

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 32,749
    • Total shares sold: 32,498

    Detailed Transactions and Holdings:

    • Acquired 32,749 shares of Common Stock (Direct)
      Date: 2026-03-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 441,739.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 32,498 shares of Common Stock at $68.1 per share (Direct)
      Date: 2026-03-08 | Code: F | equity_swap_involved: 0 | shares_owned_after: 409,241.00 | transaction_form_type: 4 | Footnotes: F2, F3

    Footnotes:

    • F1: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting on the one year anniversary of the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock.
    • F2: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person.
    • F3: Included in this number are 106,972 unvested RSUs, 32,749 of which were granted on March 8, 2026 and shall vest on March 8, 2027, 56,993 of which were granted on March 8, 2025 and shall vest through March 8, 2028, and 17,230 of which were granted on March 8, 2024 and shall vest through March 8, 2027.

Search

News categories